Connect Biopharma is trading at $1.81, down 5.96%, with no clear company-specific catalyst identified for September 4, 2026.
- Shares declined 30.07% on September 3, 2026.
- Management announced a September 15 H.C. Wainwright presentation, but it does not explain today’s decline.
- Broader indexes are modestly lower after stronger employment data, though the move is insufficient to establish causation.